2.64
-0.02(-0.75%)
Currency In USD
Address
1415 Ranch Road 620 South
Lakeway, TX 78734
United States of America
Phone
512 598 0931
Website
Sector
Healthcare
Industry
Biotechnology
Employees
2
First IPO Date
May 07, 2021
| Name | Title | Pay | Year Born |
| Mr. Richard Anthony Cunningham | Chief Executive Officer & Director | 452,058 | 1971 |
| Dr. Joseph F. Lawler M.D., Ph.D. | Founder & Chairman | 11,000 | 1973 |
| Mr. Daniel V. George | Acting Chief Financial Officer & Secretary | 194,246 | 1970 |
| Dr. Kenneth C. Cundy Ph.D. | Chief Scientific Officer | 492,756 | 1959 |
Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing and commercializing treatments for people suffering from acute cannabinoid intoxication and substance addiction. Its lead product candidate is ANEB-001, a small molecule cannabinoid receptor antagonist to treat cannabinoid intoxication and overdose. The company was incorporated in 2020 and is based in Lakeway, Texas.